chronic lymphocytic leukemia

TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics
Elias Campo, Florence Cymbalista, Paolo Ghia, Ulrich Jäger, Sarka Pospisilova, Richard Rosenquist, Anna Schuh, Stephan Stilgenbauer

Haematologica Nov 2018, haematol.2018.187583; DOI: 10.3324/haematol.2018.187583
miRNAs involvement in the pathogenesis of Richter’s syndrome
Katrien Van Roosbroeck, Recep Bayraktar, Steliana Calin, Johannes Bloehdorn, Mihnea Paul Dragomir, Keishi Okubo, Maria Teresa Sabrina Bertilaccio, Simonetta Zupo, M. James You, Gianluca Gaidano, Davide Rossi, Shih-Shih Chen, Nicholas Chiorazzi, Philip Thompson, Alessandra Ferrajoli, Francesco Bertoni, Stephan Stilgenbauer, Michael J. Keating, George A. Calin

Haematologica Nov 2018, haematol.2018.203828; DOI: 10.3324/haematol.2018.203828
Spatial clonal evolution leading to ibrutinib resistance and disease progression in chronic lymphocytic leukemia
Richárd Kiss, Donát Alpár, Ambrus Gángó, Noémi Nagy, Ediz Eyupoglu, Dóra Aczél, András Matolcsy, Judit Csomor, Zoltán Mátrai, Csaba Bödör

Haematologica Sep 2018, haematol.2018.202085; DOI: 10.3324/haematol.2018.202085
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia
Panagiotis Baliakas, Theodoros Moysiadis, Anastasia Hadzidimitriou, Aliki Xochelli, Sabine Jeromin, Andreas Agathangelidis, Mattias Mattsson, Lesley-Ann Sutton, Eva Minga, Lydia Scarfò, Davide Rossi, Zadie Davis, Neus Villamor, Helen Parker, Jana Kotaskova, Evangelia Stalika, Karla Plevova, Larry Mansouri, Diego Cortese, Alba Navarro, Julio Delgado, Marta Larrayoz, Emma Young, Achilles Anagnostopoulos, Karin E Smedby, Gunnar Juliusson, Oonagh Sheehy, Mark Catherwood, Jonathan C Strefford, Niki Stavroyianni, Chrysoula Belessi, Sarka Pospisilova, David Oscier, Gianluca Gaidano, Elias Campo, Claudia Haferlach, Paolo Ghia, Richard Rosenquist, Kostas Stamatopoulos

Haematologica Sep 2018, haematol.2018.195032; DOI: 10.3324/haematol.2018.195032
Mutations in RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia
Neus Giménez, Alejandra Martínez-Trillos, Arnau Montraveta, Mónica Lopez-Guerra, Laia Rosich, Ferran Nadeu, Juan G Valero, Marta Aymerich, Laura Magnano, Maria Rozman, Estella Matutes, Julio Delgado, Tycho Bauman, Eva Gine, Marcos González, Miguel Alcoceba, M Jose Terol, Blanca Navarro, Enrique Colado, Angel R Payer, Xose S Puente, Carlos López-Otín, Armando Lopez-Guillermo, Elias Campo, Dolors Colomer, Neus Villamor

Haematologica Sep 2018, haematol.2018.196931; DOI: 10.3324/haematol.2018.196931
Feasibility and efficacy of addition of individualized dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia
Arnon P. Kater, Marinus H.J. van Oers, Yvette van Norden, Lina van der Straten, Julia Driessen, Ward F.M. Posthuma, Martinus Schipperus, Martine E.D. Chamuleau, Marcel Nijland, Jeanette K. Doorduijn, Michel Van Gelder, Mels Hoogendoorn, Francien De Croon, Shulamiet Wittebol, J. Martijn Kerst, Erik W.A. Marijt, Reinier A.P. Raymakers, Martijn R. Schaafsma, Johan A. Dobber, Sabina A. Kersting, Mark-David Levin, HOVON CLL study group

Haematologica Aug 2018, haematol.2018.193854; DOI: 10.3324/haematol.2018.193854
Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation to GPVI
Phillip L.R. Nicolson, Craig E. Hughes, Stephanie Watson, Sophie H. Nock, Alexander T. Hardy, Callum N. Watson, Samantha J. Montague, Jean-Daniel Malcor, Mark R. Thomas, Alice Y. Pollitt, Michael G. Tomlinson, Guy Pratt, Steve P. Watson

Haematologica Jul 2018, haematol.2018.193391; DOI: 10.3324/haematol.2018.193391
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia
Silvia Martinelli, Rossana Maffei, Stefania Fiorcari, Chiara Quadrelli, Patrizia Zucchini, Stefania Benatti, Leonardo Potenza, Mario Luppi, Roberto Marasca

Haematologica Jul 2018, haematol.2017.187070; DOI: 10.3324/haematol.2017.187070
Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways
Lynne V. Abruzzo, Carmen D. Herling, George A. Calin, Christopher Oakes, Lynn L. Barron, Haley E. Banks, Vikram Katju, Michael J. Keating, Kevin R. Coombes

Haematologica Jul 2018, haematol.2018.190132; DOI: 10.3324/haematol.2018.190132
Innate lymphoid cells are expanded and functionally altered in chronic lymphocytic leukemia
Iris de Weerdt, Vera van Hoeven, J. Marius Munneke, Sanne Endstra, Tom Hofland, Mette D. Hazenberg, Arnon P. Kater

Haematologica Nov 2016, 101 (11) e461-e464; DOI: 10.3324/haematol.2016.144725

chronic lymphocytic leukemia

Pages